Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Angiogenin ELISA Kit (AC3431)
Cat.#: ASET-2020
Specifications
Description Human Angiogenin ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human Angiogenin concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 5.21 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 75-1200 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1461 Mouse MT3 ELISA Kit (AC2872) Quantitative inquiry ASET-1956 Mouse NOTCH3 ELISA Kit (AC3367) Quantitative inquiry ASET-2519 Human Laminin beta 2 ELISA Kit (AC3930) Quantitative inquiry ASET-2165 Human PZP ELISA Kit (AC3576) Quantitative inquiry ASET-1100 Human IL-6 ELISA Kit (AC2511) Quantitative inquiry ASET-2477 Porcine Slit2 ELISA Kit (AC3888) Quantitative inquiry ASET-1736 Mouse Netrin 1 ELISA Kit (AC3147) Quantitative inquiry ASET-1942 Human SEMA3B ELISA Kit (AC3353) Quantitative inquiry ASET-2403 Human FGF2 ELISA Kit (AC3814) Quantitative inquiry ASET-2452 Rat Orexin A ELISA Kit (AC3863) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket